Mayumi Namekata

Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells.

Jacqueline Murray, E. Wijelath, A. Albasanz-Puig, 2012, Biochemical and biophysical research communications.

Domain: Enhancement of VEGF Biological Activity by a Singular Growth Factor/Matrix Heparin-II Domain of Fibronectin Is a Vascular Endothelial Growth Factor-Binding

Jacqueline Murray, M. Humphries, Y. Suda, 2006 .

Heparin-II Domain of Fibronectin Is a Vascular Endothelial Growth Factor-Binding Domain: Enhancement of VEGF Biological Activity by a Singular Growth Factor/Matrix Protein Synergism

Jacqueline Murray, E. Wijelath, M. Humphries, 2006, Circulation research.

Distribution and Behavior of Radiocaesium in Water and Sediment of Retention Basins at Kashiwa City, Chiba Prefecture

S. Naito, Tomohiro Inoue, H. Ishii, 2016 .

Enhancement of capillary and cellular ingrowth in ePTFE implants with a proangiogenic recombinant construct derived from fibronectin.

Jacqueline Murray, E. Wijelath, T. Kohler, 2010, Journal of Biomedical Materials Research. Part A.

Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis.

Jacqueline Murray, E. Wijelath, M. Rosenfeld, 2011, Atherosclerosis.

Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity

Jacqueline Murray, E. Wijelath, Siyuan Zhang, 2010, Journal of cellular biochemistry.

Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis.

Jacqueline Murray, E. Wijelath, M. Rosenfeld, 2011, Atherosclerosis.